Annotation Detail
Information
- Associated Genes
- HFE
- Associated Variants
-
HFE p.Cys282Tyr (p.C282Y)
(
ENST00000357618.10,
ENST00000349999.8,
ENST00000353147.9,
ENST00000488199.5,
ENST00000397022.7,
ENST00000352392.8,
ENST00000470149.5,
ENST00000317896.11,
ENST00000309234.11,
ENST00000461397.6,
ENST00000336625.12,
ENST00000485729.2,
ENST00000714164.1,
ENST00000714170.1,
ENST00000714172.1,
ENST00000714174.1 )
HFE p.Cys282Tyr (p.C282Y) ( ENST00000309234.11, ENST00000317896.11, ENST00000336625.12, ENST00000349999.8, ENST00000352392.8, ENST00000353147.9, ENST00000357618.10, ENST00000397022.7, ENST00000461397.6, ENST00000470149.5, ENST00000485729.2, ENST00000488199.5, ENST00000714164.1, ENST00000714170.1, ENST00000714172.1, ENST00000714174.1 ) - Associated Disease
- liver carcinoma
- Source Database
- DisGeNET
- Description
- We assessed the influence of Ala16Val-superoxide dismutase 2, Pro198Leu-glutathione peroxidase 1, and -463G/A-myeloperoxidase genotypes (high activity for the Ala, Pro, and G alleles, respectively) on the risks of cirrhosis and hepatocellular carcinoma (HCC) in patients homozygous for the C282Y-hemochromatosis (HFE) gene mutation.
- Pubmed
- 20673159
- Original source reporting the Gene Disease association
- BeFree
- DisGENET score for the Gene Disease association
- 0.0440919304970895
- Year of publication
- 2011
Drugs